ArticleCell biology and toxicology2025
Ginsenoside Rh2 targets SIRT1-mediated deacetylation to modulate ERα/AR balance and overcome endocrine therapy resistance in prostate cancer using 3D organoid models.
Xinan Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.